A new Australian documentary called High as Mike is calling for improved access to medicinal cannabis for Australian patients.

The documentary, which has won the support of Australian icon Olivia Newton-John, follows the journey of Mike Gallagher in a year-long fight to be prescribed medicinal cannabis to treat a severe brain tumour.

Currently as it stands, Australian patients may receive medicinal cannabis, but only if they qualify under the Therapeutic Goods Administration’s (TGA) special access scheme (SAS), which has strict regulations.

The special access scheme allows authorised doctors to prescribe medicinal cannabis to Australian patients under “exceptional clinical circumstances”.

“Riding on a wave of realisation that a large majority of Australians are suffering and in pain, Mike is compelled to uncover the truth as he chats with patients that have already embarked on the same life changing journey,” the film’s description reads.

“Discussions with Politicians, doctors, lawyers, licensed growers and black market operators, see Mike struggling to make sense of current rules and regulations.”

Frustrated patients around Australia have turned to the black market in order to gain access to medicinal cannabis, as the Office of Drug Control struggles to keep on top of applications.

Improved access to medicinal cannabis would be amazing news for Australian companies in the sector like MGC Pharmaceuticals (ASX:MXC), who are already providing much-needed relief for patients under the SAS.

This content is produced by Star Investing in commercial partnership with MGC Pharmaceuticals. This content does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.